Fluidigm Corp. is buying DVS Sciences Inc. for $208 million.
CVS develops single-cell protein analysis systems, which are used in biological research.
Complete access to real-time information and analysis of news and trends in the industry.
14-Day Free Trial
No credit card required. Complete access to articles, breaking news and industry data.
Have an account? Sign In